.

Alnylam Pharmaceuticals reported $3.33B in Assets for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Acadia Pharmaceuticals ACAD:US $ 612.77M 11.48M
Agios Pharmaceuticals AGIO:US $ 1252.47M 83.39M
Alnylam Pharmaceuticals ALNY:US $ 3330.42M 103.13M
Amgen AMGN:US $ 59294M 98M
Arrowhead Research ARWR:US $ 751.78M 48.21M
Avrobio Inc AVRO:US $ 146.24M 29.1M
Biocryst Pharmaceuticals BCRX:US $ 510.54M 17.18M
Biomarin Pharmaceutical BMRN:US $ 6145.84M 83.13M
Bluebird Bio BLUE:US $ 573.59M 82.52M
Intercept Pharmaceuticals ICPT:US $ 498.6M 4.76M
IONIS PHARMACEUT IONS:US $ 2456.13M 62.96M
Mirati Therapeutics MRTX:US $ 1279.79M 141.51M
Moderna Inc MRNA:US 26.04B 1.57B
Neurocrine Biosciences NBIX:US $ 2005.7M 138.8M
Novartis NVS:US $ 122910M 2308M
Ptc Therapeutics PTCT:US $ 1804.06M 4.47M
Regeneron Pharmaceuticals REGN:US $ 27205.8M 857.1M
Regulus Therapeutics RGLS:US $ 54.3M 6.69M
Sangamo Biosciences SGMO:US $ 617.13M 37.18M
Sarepta Therapeutics SRPT:US $ 2996.85M 59.3M
Takeda 4502:JP Y 14065426M 887408M
Ultragenyx Pharmaceutical RARE:US $ 1320.63M 63.4M
Vertex Pharmaceuticals VRTX:US $ 15582.2M 1326.1M
Xencor XNCR:US $ 851.32M 6.6M
YTE INCY:US $ 5319.04M 264.81M